Offerings (SEC Form D)
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
Offerings at a glance — 5 offerings, 5 filings (one row per SEC file number)
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|
| 021-174455 | Mar 7, 2012 EDGAR ↗ | Mar 7, 2012 D EDGAR ↗ | 0 | $3,000,000 | $2,822,072 | Other Health Care |
| 021-159542 | May 10, 2011 EDGAR ↗ | May 10, 2011 D EDGAR ↗ | 0 | $3,000,000 | $2,832,506 | Other Health Care |
| 021-146902 | Aug 25, 2010 EDGAR ↗ | Aug 25, 2010 D EDGAR ↗ | 0 | $3,896,276 | $3,896,276 | Other Health Care |
| 021-143374 | Jun 11, 2010 EDGAR ↗ | Jun 11, 2010 D EDGAR ↗ | 0 | $835,000 | $815,598 | Other Health Care |
| 021-78500 | Aug 7, 2009 EDGAR ↗ | Aug 7, 2009 D EDGAR ↗ | 0 | Indefinite | $8,502,776 | Other Health Care |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
Mar 7, 2012 D Other Health Care — $2,822,072 sold of $3,000,000 · 19 investors EDGAR ↗
| Filing | Form D filed Mar 7, 2012SEC file no. 021-174455 · accession 0001331350-12-000001 |
|---|
| Raise progress | $2,822,072 sold of $3,000,000 offered (94%) · $177,928 remaining · first sale Feb 24, 2012 |
|---|
| Filing timing | Date of first sale: Feb 24, 2012 · Form D filed: Mar 7, 2012 (12 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 5,356 days (14.7 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 19 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Debt; Option, warrant or other right to acquire |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | John Wass, Chief Executive Officer (Mar 7, 2012) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
May 10, 2011 D Other Health Care — $2,832,506 sold of $3,000,000 · 17 investors EDGAR ↗
| Filing | Form D filed May 10, 2011SEC file no. 021-159542 · accession 0001331350-11-000001 |
|---|
| Raise progress | $2,832,506 sold of $3,000,000 offered (94%) · $167,494 remaining · first sale Apr 25, 2011 |
|---|
| Filing timing | Date of first sale: Apr 25, 2011 · Form D filed: May 10, 2011 (15 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 5,661 days (15.5 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 17 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Debt |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | John Wass, Chief Executive Officer (May 10, 2011) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Aug 25, 2010 D Other Health Care — $3,896,276 sold of $3,896,276 · 20 investors EDGAR ↗
| Filing | Form D filed Aug 25, 2010SEC file no. 021-146902 · accession 0001331350-10-000003 |
|---|
| Raise progress | $3,896,276 sold of $3,896,276 offered (100%) · $0 remaining · first sale Aug 12, 2010 Issuer's note: Amount sold includes note conversion. |
|---|
| Filing timing | Date of first sale: Aug 12, 2010 · Form D filed: Aug 25, 2010 (13 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 5,917 days (16.2 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 20 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 Issuer's note: Proceeds will be used for working capital |
|---|
| Signed by | John Wass, Chief Executive Officer (Aug 25, 2010) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Jun 11, 2010 D Other Health Care — $815,598 sold of $835,000 · 9 investors EDGAR ↗
| Filing | Form D filed Jun 11, 2010SEC file no. 021-143374 · accession 0001331350-10-000002 |
|---|
| Raise progress | $815,598 sold of $835,000 offered (98%) · $19,402 remaining · first sale May 28, 2010 |
|---|
| Filing timing | Date of first sale: May 28, 2010 · Form D filed: Jun 11, 2010 (14 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 5,993 days (16.4 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 9 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Debt; Security to be acquired upon exercise |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 Issuer's note: Proceeds will be used for working capital |
|---|
| Signed by | John Wass, Chief Executive Officer (Jun 10, 2010) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Aug 7, 2009 D Other Health Care — $8,502,776 sold of Indefinite · 26 investors EDGAR ↗
| Filing | Form D filed Aug 7, 2009SEC file no. 021-78500 · accession 0001331350-09-000002 |
|---|
| Raise progress | $8,502,776 sold of Indefinite offered · Indefinite remaining · first sale Jan 31, 2008 Issuer's note: THIS FILING IS ACTUALLY AN AMENDMENT TO A FORM D THAT THE SEC MISFILED ON FEB. 19, 2008 UNDER CIK 1301909 (WAVEMARKET, INC.) INSTEAD OF THE ISSUER'S CORRECT CIK 1331350 (WAVEMARK, INC.) TO DATE THE SEC HAS NOT CORRECTED THIS ERROR. |
|---|
| Filing timing | Date of first sale: Jan 31, 2008 · Form D filed: Aug 7, 2009 (554 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 6,841 days (18.7 years) |
|---|
| Annual amendments | Issuer reported the offering may last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 26 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Security to be acquired upon exercise |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 Issuer's note: PROCEEDS WILL BE USED FOR WORKING CAPITAL. |
|---|
| Signed by | JOHN WASS, CHIEF EXECUTIVE OFFICER AND SECRETARY (Jul 29, 2009) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Mar 7, 2012. Industry as reported, by offering: All 5 offerings reported: Other Health Care (2009–2012).
Key people 10
Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|
| AP Andrew Pforzheimer | Director | MA | May 10, 2011 → Mar 7, 2012 on 2 of 5 filings listed on the latest filing | — |
| BS Benson Shapiro | Director | MA | Aug 7, 2009 → Mar 7, 2012 on 5 of 5 filings listed on the latest filing | — |
| JT Jeff Templer | Executive Officer | MA | Mar 7, 2012 on 1 of 5 filings listed on the latest filing | — |
| JW John Wass | Executive Officer, Director | MA | Aug 7, 2009 → Mar 7, 2012 on 5 of 5 filings listed on the latest filing | — |
| MF Michael Finney | Director | CA, MA | Aug 7, 2009 → Mar 7, 2012 on 5 of 5 filings listed on the latest filing | 3 other issuers |
| VH Victoria Hamilton | Director | NY | Aug 7, 2009 → Mar 7, 2012 on 5 of 5 filings listed on the latest filing | — |
| JI Joseph Impellizeri | Executive Officer | MA | Aug 25, 2010 on 1 of 5 filings not listed on the latest filing (Mar 7, 2012) | — |
| PL Patrick Littlefield | Executive Officer, Director | MA | Aug 7, 2009 → Aug 25, 2010 on 3 of 5 filings not listed on the latest filing (Mar 7, 2012) | — |
| PA Pforzheimer Andrew | Director | MA | Aug 25, 2010 on 1 of 5 filings not listed on the latest filing (Mar 7, 2012) | — |
| JI Joe Impellizeri also filed as JOE Impellizeri | Executive Officer | MA | Aug 7, 2009 → Jun 11, 2010 on 2 of 5 filings not listed on the latest filing (Mar 7, 2012) | — |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (each spelling that has its own person page is linked); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.
Connections
Other issuers listing the same people:
Shared address: this business address appears on filings for 2 other issuers. Stated as a count only (suite numbers ignored) — many addresses are shared office buildings or registered agents. As of Oct 23, 2026, 5:45 PM ET.
Other offering types (Regulation A and Regulation Crowdfunding)
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Adviser registration (Form ADV)
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched WaveMark Inc.
Meta advertising
No Meta Pixel ids or Facebook / Instagram page links on file for WaveMark Inc as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.
Public profiles
Public profiles official links and public statements, each with its source and date
No website or social profile named in WaveMark Inc's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #344,503 of 374,652 in line (14 issuers searched so far).
Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for MA yet).
Export this report as PDF (all source links + data timestamp) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
Corrections log
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.
Email me the full report
The complete public-record profile for WaveMark Inc, plus the weekly new-filings list.
What do you want to do?
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Request a correction
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).
Sponsor response
Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.
Claim this profile (sponsors)
Free. Get the "Claimed by sponsor" chip and a confirmed contact for corrections. Claiming never changes the public-record section.